Metabolomics-based methods for early disease diagnostics

G. A.Nagana Gowda, Shucha Zhang, Haiwei Gu, Vincent Asiago, Narasimhamurthy Shanaiah, Daniel Raftery

Research output: Contribution to journalReview article

326 Citations (Scopus)

Abstract

The emerging field of metabolomics, in which a large number of small-molecule metabolites from body fluids or tissues are detected quantitatively in a single step, promises immense potential for early diagnosis, therapy monitoring and for understanding the pathogenesis of many diseases. Metabolomics methods are mostly focused on the information-rich analytical techniques of NMR spectroscopy and mass spectrometry (MS). Analysis of the data from these high-resolution methods using advanced chemometric approaches provides a powerful platform for translational and clinical research and diagnostic applications. In this review, the current trends and recent advances in NMR- and MS-based metabolomics are described with a focus on the development of advanced NMR and MS methods, improved multivariate statistical data analysis and recent applications in the area of cancer, diabetes, inborn errors of metabolism and cardiovascular diseases.

Original languageEnglish (US)
Pages (from-to)617-633
Number of pages17
JournalExpert Review of Molecular Diagnostics
Volume8
Issue number5
DOIs
StatePublished - Sep 1 2008
Externally publishedYes

Fingerprint

Metabolomics
Mass Spectrometry
Inborn Errors Metabolism
Statistical Data Interpretation
Translational Medical Research
Body Fluids
Secondary Prevention
Early Diagnosis
Cardiovascular Diseases
Magnetic Resonance Spectroscopy
Neoplasms

Keywords

  • Cancer
  • Coronary heart disease
  • Diabetes
  • Early detection
  • Inborn errors of metabolism
  • Mass spectrometry
  • Metabolomics
  • Metabonomics
  • Multivariate statistical analysis
  • NMR spectroscopy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Gowda, G. A. N., Zhang, S., Gu, H., Asiago, V., Shanaiah, N., & Raftery, D. (2008). Metabolomics-based methods for early disease diagnostics. Expert Review of Molecular Diagnostics, 8(5), 617-633. https://doi.org/10.1586/14737159.8.5.617

Metabolomics-based methods for early disease diagnostics. / Gowda, G. A.Nagana; Zhang, Shucha; Gu, Haiwei; Asiago, Vincent; Shanaiah, Narasimhamurthy; Raftery, Daniel.

In: Expert Review of Molecular Diagnostics, Vol. 8, No. 5, 01.09.2008, p. 617-633.

Research output: Contribution to journalReview article

Gowda, GAN, Zhang, S, Gu, H, Asiago, V, Shanaiah, N & Raftery, D 2008, 'Metabolomics-based methods for early disease diagnostics', Expert Review of Molecular Diagnostics, vol. 8, no. 5, pp. 617-633. https://doi.org/10.1586/14737159.8.5.617
Gowda, G. A.Nagana ; Zhang, Shucha ; Gu, Haiwei ; Asiago, Vincent ; Shanaiah, Narasimhamurthy ; Raftery, Daniel. / Metabolomics-based methods for early disease diagnostics. In: Expert Review of Molecular Diagnostics. 2008 ; Vol. 8, No. 5. pp. 617-633.
@article{6f9fe93898714a098d040e6f5eb21dc0,
title = "Metabolomics-based methods for early disease diagnostics",
abstract = "The emerging field of metabolomics, in which a large number of small-molecule metabolites from body fluids or tissues are detected quantitatively in a single step, promises immense potential for early diagnosis, therapy monitoring and for understanding the pathogenesis of many diseases. Metabolomics methods are mostly focused on the information-rich analytical techniques of NMR spectroscopy and mass spectrometry (MS). Analysis of the data from these high-resolution methods using advanced chemometric approaches provides a powerful platform for translational and clinical research and diagnostic applications. In this review, the current trends and recent advances in NMR- and MS-based metabolomics are described with a focus on the development of advanced NMR and MS methods, improved multivariate statistical data analysis and recent applications in the area of cancer, diabetes, inborn errors of metabolism and cardiovascular diseases.",
keywords = "Cancer, Coronary heart disease, Diabetes, Early detection, Inborn errors of metabolism, Mass spectrometry, Metabolomics, Metabonomics, Multivariate statistical analysis, NMR spectroscopy",
author = "Gowda, {G. A.Nagana} and Shucha Zhang and Haiwei Gu and Vincent Asiago and Narasimhamurthy Shanaiah and Daniel Raftery",
year = "2008",
month = "9",
day = "1",
doi = "10.1586/14737159.8.5.617",
language = "English (US)",
volume = "8",
pages = "617--633",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Metabolomics-based methods for early disease diagnostics

AU - Gowda, G. A.Nagana

AU - Zhang, Shucha

AU - Gu, Haiwei

AU - Asiago, Vincent

AU - Shanaiah, Narasimhamurthy

AU - Raftery, Daniel

PY - 2008/9/1

Y1 - 2008/9/1

N2 - The emerging field of metabolomics, in which a large number of small-molecule metabolites from body fluids or tissues are detected quantitatively in a single step, promises immense potential for early diagnosis, therapy monitoring and for understanding the pathogenesis of many diseases. Metabolomics methods are mostly focused on the information-rich analytical techniques of NMR spectroscopy and mass spectrometry (MS). Analysis of the data from these high-resolution methods using advanced chemometric approaches provides a powerful platform for translational and clinical research and diagnostic applications. In this review, the current trends and recent advances in NMR- and MS-based metabolomics are described with a focus on the development of advanced NMR and MS methods, improved multivariate statistical data analysis and recent applications in the area of cancer, diabetes, inborn errors of metabolism and cardiovascular diseases.

AB - The emerging field of metabolomics, in which a large number of small-molecule metabolites from body fluids or tissues are detected quantitatively in a single step, promises immense potential for early diagnosis, therapy monitoring and for understanding the pathogenesis of many diseases. Metabolomics methods are mostly focused on the information-rich analytical techniques of NMR spectroscopy and mass spectrometry (MS). Analysis of the data from these high-resolution methods using advanced chemometric approaches provides a powerful platform for translational and clinical research and diagnostic applications. In this review, the current trends and recent advances in NMR- and MS-based metabolomics are described with a focus on the development of advanced NMR and MS methods, improved multivariate statistical data analysis and recent applications in the area of cancer, diabetes, inborn errors of metabolism and cardiovascular diseases.

KW - Cancer

KW - Coronary heart disease

KW - Diabetes

KW - Early detection

KW - Inborn errors of metabolism

KW - Mass spectrometry

KW - Metabolomics

KW - Metabonomics

KW - Multivariate statistical analysis

KW - NMR spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=52049108458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52049108458&partnerID=8YFLogxK

U2 - 10.1586/14737159.8.5.617

DO - 10.1586/14737159.8.5.617

M3 - Review article

VL - 8

SP - 617

EP - 633

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7159

IS - 5

ER -